According to the NCI website, Tagraxofusp is a recombinant protein consisting of human interleukin 3 (IL3) fused to the first 388 amino acids of diphtheria toxin [DT(388)] (DT388IL3) with potential antineoplastic activity.  Check for active clinical trials using this agent. (NCI Thesaurus)

Patient information

• Tazemetostat is used to treat locally advanced and metastatic epithelioid sarcoma.

More Information in English:

Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health

Link to MedlinePlus, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute

Wiki

Info for Patients presented by Scott Hamilton from Chemocare.com